DENGUE VIRUSES
S. Nahidha Begum
II. M.Sc Microbiology
Sacred Heart College
DENGUE VIRUSES
Introduction
Dengue is a viral infection transmitted by mosquitoes.
There are four serotypes of the dengue virus: DEN-1, DEN-2, DEN-3, and
DEN-4.
The illness caused by dengue ranges from mild fever to severe, life-
threatening conditions.
PROPERTIES OF DENGUE VIRUS
Arbovirus
 Belongs to the family Flaviviridae and genus Flavivirus
 Transmitted by arthropods, primarily mosquitoes.
Dengue Serotypes
 Four serotypes: DEN-1, DEN-2, DEN-3, DEN-4.
 Serotypes differ in genetic makeup, antigenic properties, and geographic distribution.
Mosquito Vector
 The primary vector is Aedes aegypti, a mosquito that bites during the day.
STRUCTURE OF DENGUE VIRUS
Shape: Spherical and enveloped, approximately 50 nm in diameter.
Envelope: Contains glycoproteins that facilitate virus attachment and
entry into host cells.
Genome: Composed of a single-stranded, positive-sense RNA, roughly
11 kb in length.
Proteins: Encodes for three structural and seven non-structural proteins
necessary for virus replication.
DENGUE VIRUS REPLICATION MECHANISM
 Attachment: Virus attaches to host cell receptors, initiating endocytosis.
 Uncoating: The virus releases its RNA genome into the cytoplasm.
 Translation: The viral RNA is translated into polyproteins.
 Proteolytic Processing: Polyproteins are cleaved into individual viral proteins by
cellular and viral proteases.
 Replication: Genomic RNA is used as a template for synthesizing new RNA and
viral proteins.
 Assembly and Release: New virus particles are assembled and released from the
cell.
PATHOGENESIS OF DENGUE VIRUS
 Infection of Dendritic Cells: The virus enters dendritic cells in the
skin via mosquito bites.
 Dissemination via Lymphatics: The virus spreads through the
lymphatic system to other tissues.
 Platelet Activation: Infected platelets activate and release
inflammatory cytokines and chemokines.
TRANSMISSION MODES OF DENGUE VIRUS
Mosquito Bites: Transmitted by Aedes aegypti and Aedes albopictus
mosquitoes.
Vertical Transmission: From mother to fetus during pregnancy or
childbirth.
Blood Transfusion: Through infected blood transfusion or organ
transplantation.
Sexual Transmission: Rare, but possible.
SYMPTOMS AND CLINICAL MANIFESTATIONS
Mild Dengue Fever:
 Fever
 Headache
 Retro-orbital pain
 Muscle and joint pain
 Rash
Severe Dengue Fever:
 Severe headache
 Joint and muscle pain
SYMPTOMS AND CLINICAL MANIFESTATIONS
 Bleeding manifestations
 Plasma leakage
 Organ impairment
Dengue Shock Syndrome:
 Severe plasma leakage
 Hypotension
 Shock
 Organ failure
LABORATORY DIAGNOSIS
Serology: Detection of IgM and/or IgG antibodies to dengue
virus.
 Molecular: RT-PCR to detect viral RNA.
Virus Isolation: Growth in cell culture or animal models.
TREATMENT AND PREVENTION
 Treatment:
 No specific treatment; supportive care with antipyretics and analgesics.
 Prevention:
 Mosquito control
 Use of protective clothing and mosquito repellents
 Vaccination:
 CYD-TDV vaccine (a live recombinant tetravalent vaccine) provides partial protection
against dengue.
THANK YOU

Understanding the Dengue Virus : Symptoms, Transmission, and Prevention.

  • 1.
    DENGUE VIRUSES S. NahidhaBegum II. M.Sc Microbiology Sacred Heart College
  • 2.
    DENGUE VIRUSES Introduction Dengue isa viral infection transmitted by mosquitoes. There are four serotypes of the dengue virus: DEN-1, DEN-2, DEN-3, and DEN-4. The illness caused by dengue ranges from mild fever to severe, life- threatening conditions.
  • 3.
    PROPERTIES OF DENGUEVIRUS Arbovirus  Belongs to the family Flaviviridae and genus Flavivirus  Transmitted by arthropods, primarily mosquitoes. Dengue Serotypes  Four serotypes: DEN-1, DEN-2, DEN-3, DEN-4.  Serotypes differ in genetic makeup, antigenic properties, and geographic distribution. Mosquito Vector  The primary vector is Aedes aegypti, a mosquito that bites during the day.
  • 4.
    STRUCTURE OF DENGUEVIRUS Shape: Spherical and enveloped, approximately 50 nm in diameter. Envelope: Contains glycoproteins that facilitate virus attachment and entry into host cells. Genome: Composed of a single-stranded, positive-sense RNA, roughly 11 kb in length. Proteins: Encodes for three structural and seven non-structural proteins necessary for virus replication.
  • 5.
    DENGUE VIRUS REPLICATIONMECHANISM  Attachment: Virus attaches to host cell receptors, initiating endocytosis.  Uncoating: The virus releases its RNA genome into the cytoplasm.  Translation: The viral RNA is translated into polyproteins.  Proteolytic Processing: Polyproteins are cleaved into individual viral proteins by cellular and viral proteases.  Replication: Genomic RNA is used as a template for synthesizing new RNA and viral proteins.  Assembly and Release: New virus particles are assembled and released from the cell.
  • 6.
    PATHOGENESIS OF DENGUEVIRUS  Infection of Dendritic Cells: The virus enters dendritic cells in the skin via mosquito bites.  Dissemination via Lymphatics: The virus spreads through the lymphatic system to other tissues.  Platelet Activation: Infected platelets activate and release inflammatory cytokines and chemokines.
  • 7.
    TRANSMISSION MODES OFDENGUE VIRUS Mosquito Bites: Transmitted by Aedes aegypti and Aedes albopictus mosquitoes. Vertical Transmission: From mother to fetus during pregnancy or childbirth. Blood Transfusion: Through infected blood transfusion or organ transplantation. Sexual Transmission: Rare, but possible.
  • 8.
    SYMPTOMS AND CLINICALMANIFESTATIONS Mild Dengue Fever:  Fever  Headache  Retro-orbital pain  Muscle and joint pain  Rash Severe Dengue Fever:  Severe headache  Joint and muscle pain
  • 9.
    SYMPTOMS AND CLINICALMANIFESTATIONS  Bleeding manifestations  Plasma leakage  Organ impairment Dengue Shock Syndrome:  Severe plasma leakage  Hypotension  Shock  Organ failure
  • 10.
    LABORATORY DIAGNOSIS Serology: Detectionof IgM and/or IgG antibodies to dengue virus.  Molecular: RT-PCR to detect viral RNA. Virus Isolation: Growth in cell culture or animal models.
  • 11.
    TREATMENT AND PREVENTION Treatment:  No specific treatment; supportive care with antipyretics and analgesics.  Prevention:  Mosquito control  Use of protective clothing and mosquito repellents  Vaccination:  CYD-TDV vaccine (a live recombinant tetravalent vaccine) provides partial protection against dengue.
  • 12.